Author

B. C. Cho

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Arabo· 1 shared A. B. Cortot· 1 shared A. Bardelli· 1 shared A. Guernet· 1 shared A. Kim· 1 shared A. Vinchent· 1 shared A.-Y. Lee· 1 shared B. Carreno· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Arabo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells

L. Brunet, D. Alexandre, J. Lee, M. d. M. Blanquer-Rossello, A. Guernet, H. Chhouri, Z. Kherrouche, A. Arabo, S. Yao, D. Godefroy, J. Dehedin, J.-R. Li, C. Duparc, P. Jamme, A. Vinchent, , L. Grumolato

This study shows that sorafenib can prolong lung cancer response to EGFR inhibitors by targeting resistant cells' selective advantage.

bioRxiv · Jun 19, 2023Cancer Biology

In vitro validation of neoantigen prediction algorithm for developing personalized cancer vaccine therapy

Y.-j. Choe, E. Kim, J. Oh, M. Jang, W. Fu, H. Lee, M. Jung, K.-H. Pyo, C.-B. Synn, S. Kim, Y. Yang, A. Kim, B. C. Cho, H. S. Kim, S. Kim, , S. Paik

The paper validates a neoantigen prediction algorithm, Neopepsee, by testing its immunogenicity using ELISpot assays on patient-derived samples and compares it to pVACseq.

bioRxiv · Dec 12, 2021 · PreprintImmunology

Regeneration of a Full-Thickness Defect in Rotator Cuff Tendon with Umbilical Cord-Derived Mesenchymal Stem Cells in a Rat Model

J.-H. Yea, I. Kim, G. Sym, J.-K. Park, A.-Y. Lee, B. C. Cho, T. S. Bae, B. J. Kim, C. Jo

This study evaluates the efficacy of umbilical cord-derived mesenchymal stem cells (UC MSCs) in regenerating full-thickness rotator cuff defects in a rat model, showing improvements in macroscopic, histological, and biomechanical outcomes.

bioRxiv · Jun 12, 2020Pathology